Literature DB >> 31477792

Childhood iron deficiency anemia leads to recurrent respiratory tract infections and gastroenteritis.

Jayaweera Arachchige Asela Sampath Jayaweera1, Mohammed Reyes2, Anpalaham Joseph3.   

Abstract

Anemia affects approximately 30% of children all over the world. Acute respiratory tract infections (ARTI), urinary tract infections (UTI) and gastroenteritis (GE) are common infectious entities in children. Here, we assessed the association between anemia and development of recurrent ARTI, UTI, and GE in children. This was a case-control study in hospitalized 2-5 years old children in Professorial Pediatric Unit at Teaching Hospital Anuradhapura, Sri Lanka. An 18-month follow up was done to assess the risk factors for the development of recurrent ARTI, GE, UTI, and control presented without infections. Further, 6-month follow up done after 3-month iron supplementation to assess the occurrence of recurrences. Blood Hb concentration was measured using Drabking's reagent. Logistic regression was used to find the risk factors for the development of recurrences. In ARTI, 121/165 (73.3%), GE, 88/124 (71%), UTI 46/96 (47.9%) and control 40/100 (40%) were having anemia. Initial ARTI group, recurrent ARTI was 24 (14.5%, p = 0.03); initial GE group: recurrent GE was 14 (11.3%, p = 0.03), recurrent ARTI was 11 (8.9%, p = 0.04); initial UTI group, development of; recurrent UTI was 8 (8.3%, p = 0.04); control, recurrent ARTI was 11 (11%, p = 0.03). Following 3-month iron supplementation reduction of recurrences was significant: initial ARTI recurrent ARTI in 90%, recurrent GE in 77.7%; initial GE recurrent GE in 83.3%, recurrent ARTI in 80%; initial UTI recurrent ARTI in 71.4% and control recurrent ARTI in 88.8%. Iron deficiency is a major type of anemia and anemic children are more prone to develop recurrent ARTI and GE. Once iron deficiency being corrected the rate of recurrent ARTI and GE was reduced. This would be a boost for policy developers to implement strategies at the community level to prevent iron deficiency in children to reduce ARTI and GE recurrences.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31477792      PMCID: PMC6718651          DOI: 10.1038/s41598-019-49122-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Acute infective episodes in children are quite common and are associated with high morbidity and mortality[1]. Acute respiratory tract infections (ARTI), urinary tract infections (UTI) and gastroenteritis (GE) are such common infectious entities[2-5]. In the globe, infections following bacteria and viruses play a significant role while parasites and fungi are emerging and threatening[6,7]. The disease burden following childhood ARTI is greater than that of any other cause of disease[1]. In 2014, 18% of mortality for children younger than 5 years of age was caused by ARTI while the diarrheal disease is the next greatest[8,9]. UTI in children <5 years of age the associated burden is 4%. Further the overall conclusion one out of 20 girls and one out of 50 boys will have a UTI by the age of 5 years, with a predominance of boys during the neonatal period and early infancy[10]. Overall burden following these 3 major acute childhood infections is substantial thus impact on the globe and the country economy is enormous[11]. Following entry of microorganism to the organ vicinity several factors concurrently contribute for the development of the infection. When considering host-parasite interface nutritional status of the host is one of the key contributory factors for invasion and development of infections[12-14]. Hemoglobin (Hb) concentration is a parameter that reflects the chronic nutritional status and also blood oxygen carrying capacity[15,16]. Children are at a rapid growth state thus demand the nutrition is enormous[17]. Simultaneously, the tendency to develop under-nutrition is also high. In such instances, the risk for development of infection is high and the vicious cycle continues leads to poor-nutrition[18]. Anemia is affecting approximately 30% of children all over the world[19,20]. Several factors are contributed to anemia. In childhood, nutritional anemia including iron, vitamin B-12, and folate deficiency is the commonest[21]. In addition to the nutritional, hereditary type of anemia including thalassemia, sickle cell anemia and aplastic variety following bone marrow suppression is observed[22]. Irrespective of the etiology following anemia, child suffers fatigability and its negative effect on growth is great. Iron deficiency anemia in children occurs most frequently between the age of 6 months and 3 years, the period of age when repeated infections occur[23]. Anemia associated lower ARTI occurs more commonly in children than in adults. Recurrent ARTI and UTI are common in children and following development of recurrences the associated burden would worsen[24,25]. Recurrent infective episodes invariably lead to undernutrition[26]. Perhaps, anemia is a well-known risk factor for recurrent infective episodes[27]. In addition, studies on hemoglobin level and development of multiple episodes of otitis media in children been discussed[28]. In a cross-sectional case-control study anemia and occurrence of acute gastroenteritis also been discussed among children in Gaza strip[29]. In contrast, anemia and development of recurrent UTI are not been well described in the literature. Another hand if a child develops recurrent infections possibility of immunodeficiency need to be excluded[30]. Irrespective to the etiology of anemia, the relation between low hemoglobin (Hb) level and occurrence of infections has not been fully evaluated, and only a few reports are available[31]. This study would assess the Hb status and development of acute as well as recurrent ARTI, UTI, and GE in children.

Method

This was a case-control study in hospitalized 2–5 years old children with ARTI, UTI, and GE over March 2014 to August 2014. To participate in the study informed written consent obtained from the legal guardians/parents. As a control, children presented to the outpatient department to seek treatment for traumatic surgical cases who were having past 6-month period free of any acute or chronic infections were included. Children having pulmonary, cardiac, gastrointestinal and urogenital structural and functional anomalies were excluded from the study. Patients who undergo repeated blood transfusions were excluded from the study. Further, children with known immunodeficiencies were also excluded from the study. The study was performed at the pediatric ward, Professorial Unit, Teaching Hospital Anuradhapura, Sri Lanka. Participants including controls were followed up 18 months to assess the occurrence of recurrent ARTI, GE and UTI and the risk factors. This was done following weekly telephone conversations with the guardians. In each episode they were asked to admit to the Professorial Unit, Teaching Hospital Anuradhapura, Sri Lanka. Further, a period of 6 months was followed up following iron supplementation (3-month period) to assess the development of recurrent infections. They were followed up in similar manner. All methods and protocols were performed in accordance with the relevant approved guidelines and regulations. ARTI cases with Severe Acute Respiratory Illness (SARI) defined by WHO were included. A child has a fever with dysuria (crying while micturition) and or hematuria was included as UTI. Sudden onset of diarrhea and/or vomiting, usually three or more bouts of diarrhea or vomiting were taken as GE. A hundred patients in age 2–5 years who visited the outpatient department for surgical problems were taken as a control. Definition of recurrent ARTI is arbitrary, too generic, restrictive and for our study: recurrent infectious rhinitis as more than five episodes per year and recurrent pharyngitis or tonsillitis more than three episodes within 12 months. For the lower respiratory tract, we have taken ≥3 episodes per 12 months. Similarly, for recurrent GE we have taken ≥3 episodes per 12 months while for the clarity cases with chronic diarrhea were excluded. Recurrent urinary tract infection (UTI) refers to ≥2 infections in six months or ≥3 infections in one year. For anemia when hemoglobin level was considered age-specific 13- ≤ 24 months [mean 12.0 g/dL (−2SD: 11.0 g/dL)] and 25- ≤ 60 months [mean 12.5 g/dL (−2SD: 11.5 g/dL)] *Brian Yang Merritt’s Haemoglobin concentration (http://emedicine.medscape.com/article/2085614-overview) below 2 standard deviation (SD)[32]. Children with ARTI nasopharyngeal aspirates (NPAs) collected with the help of recommended mucus extractor by the pediatrician/prior trained medical doctor (research candidate). Indirect immunofluorescence assay was performed by DAKO IMAGEN™ (United Kingdom)[33], respiratory screening reagents for 8 respiratory viruses and viral typing was done for each of RSV, adeno, parainfluenza 1, 2 & 3, influenza A & B and Human metapneumovirus (hMPV) viruses using monoclonal antibodies DAKO IMAGEN™ (United Kingdom). Children with UTI were having significant (single isolate or mixed > 105) and culture growth from clean caught urine was taken as having bacterial UTI. In GE stool full report was having a significant number of pus cells considered. The collected human fecal samples were tested in duplicate for Group A rotavirus and Adenovirus using a commercially available qualitative enzyme immunoassay (ProSpectTM Rotavirus Microplate Assay manufactured by Oxoid Ltd, UK and ProSpectTM Adenovirus Microplate Assay manufactured by Oxoid Ltd, UK, respectively), following the manufacturer’s instructions. Each stool was inoculated into selenite brilliant green sulfa enrichment broth (Oxoid Ltd, Basingstoke, UK) at 37 °C for 18 h, and was then plated onto Salmonella-Shigella agar (Oxoid Ltd, Basingstoke, UK) and xylose lysine deoxycholate agar (Oxoid Ltd, Basingstoke, UK) to detect non typhoidal salmonellosis and Shigella spp. strains, after an 18 h incubation at 37 °C. The suspicious colony was plated onto CHROMagar™ Salmonella medium (CHROMagar, Paris, France) and cultivated at 37 °C for 18 h. Each stool sample was directly inoculated onto alkaline peptone water (Oxoid Ltd, Basingstoke, UK) at 37 °C for 18 h to examine for Vibrio cholera, Vibrio parahaemolyticus, Aeromonas spp., and Plesiomonas spp., and was then plated onto thiosulfate-citrate-bile salts-sucrose agar (Oxoid Ltd, Basingstoke, UK) at 37 °C for 18 h. Suspicious colonies were selected to conduct the oxidase experiment. If the oxidase test resulted in a positive reading, the systematic biochemical identification for these suspicious colonies was confirmed. Stool iodine staining, wet smear, and microscopy were performed to assess amoebic cysts, oocytes, and other helminth oocytes and larvae. In addition to that fecal reducing substances, the level was taken to exclude lactose intolerance and malabsorption syndromes. Blood Hb concentration from all participants was measured using Drabking’s reagent using a spectrophotometer. Blood picture analysis and serum ferritin levels were measured to define the etiology for anemia. An investigator administered questionnaire was used to collect patients’ demography, nutritional status, clinical presentation, and past medical history. For iron deficiency anemia following a period of 3-month of oral iron supplementation (weight/based) the subjects were further followed up over 6-month to observe the development of recurrent ARTI, GE and UTI. Children with hemoglobin 9–10 g/dL were supplemented with 60–120 mg of iron. Hemoglobin concentration, blood picture (normochromic and normocytic) and assessment of serum ferritin level was done to confirm the cure of iron deficiency anemia. Data obtained were double entered into a spreadsheet database prepared with Microsoft® Excel and compared and cleaned for wrong entries. Statistical analysis was done using SAS version 9.1 (SAS, 2005, New Jersey)[34]. Association of each of the categorical variable with response variable was assessed by Chi-square test. Variables showing statistically significant association in univariate analysis with the outcome variable were considered as a risk factor. Only those variables were subjected to multivariate analysis. Logistic regression method was used to find the risk factor for the development of recurrent ARTI, UTI, and GE. In multivariate analysis, variables showing P < 0.05 were considered to be statistically significant. Continuous variables were expressed as a measure of central tendency.

Ethics approval and consent to participate

Ethical approval for all experimental protocol/s were approved by ethical review and publication committee, University of Peradeniya, Sri Lanka and to participate in the study informed written consent obtained from the legal guardians/parents.

Results

Over the period of the initial 18 months, children with clinically suspected 165 cases of ARTI, 124 cases of GE, 96 cases of UTI and 100 control were enrolled in the study. Children with suspected ARTI, 65 (39.3%) cases of viral ARTI was detected based on IFA, mean age of presentation was 2.4 ± 0.5 years and mean hospital stay was 4 ± 2 days while 58% were males and 42% females. Children with GE, 62 (50%) viral, 12 (10%) bacterial cases detected based on viral ELISA and stool bacterial cultures respectively. The mean age of presentation of GE was 2.5 ± 0.8 years and mean hospital stay was 5 ± 2.5 days while 57% were males and 43% females. Children with UTI, 52 (54.1%) had culture-positive UTI mean age of presentation was 2.45 ± 0.7 years and mean hospital stay was 3 ± 2.4 days while 55% were males and 45% females. In control, 52% were males and 48% were females. In all including the control, male predominance (p = 0.03) with no significant difference between mean age and mean hospital stay was detected. Out of 165 children with ARTI, 121 were anemics (73.3%). Eighty-eight children out of 124 with GE and (71%) and 46 out of 96 children with UTI were having anemia (47.9%). In control subjects, 40 of them were having anemia (40%). When compared the diseased groups and the control, children with ARTI and GE were having anemia significantly (p = 0.03 and 0.04 respectively) whiles children with UTI, anemia was not significant (P > 0.05) (Table 1).
Table 1

Details of recurrent infections before, after 3 month of iron supplementation and 6 months follow up.

Initial group (n)ARTI (165)GE (124)UTI (96)Control (100)P value and comments
Percentage of Iron deficiency anemia (%) 121 (73.3%) 86 (71.0%) 44 (47.9%) 40 (40%) 0.03
Recurrent infections among anemics (%)

ARTI

20

(16.5%)

GE

9

(7.4%)

GE

12

(14%)

ARTI

10

(11.6%)

ARTI

7

(16%)

ARTI

9

(22.5%)

Recurrent infections among anemics (%)

ARTI

4

(2.4%)

GE

2

(1.6%)

GE

2

(1.6%)

ARTI

1

(0.8%)

ARTI

1

(1%)

ARTI

2

(2%)

Initial Hb (g/dl)9.6 ± 0.89.5 ± 0.79.7 ± 0.89.6 ± 0.9
Initial serum ferritin (ng/ml)4.5 ± 1.24.5 ± 1.14.5 ± 1.25.5 ± 0.3
3-month Iron supplementation
Initial group ARTI GE UTI Control
At 3-month Hb (g/dl)11.3 ± 0.2*11.6 ± 0.4*11.4 ± 0.3*11.9 ± 0.3*0.03*
serum ferritin (ng/ml)12.6 ± 0.8**12.6 ± 0.4**12.6 ± 0.8**12.2 ± 0.7**0.02**
Follow up- 6 months
Recurrent infection

ARTI

2

(1.6%)

GE

2

(1.6%)

GE

2

(2.3%)

ARTI

2

(2.3%)

ARTI

2

(4.5%)

ARTI

1

(2.5%)

At 6-month Hb (g/dl)11.6 ± 0.412.1 ± 0.612.4 ± 0.311.9 ± 0.2
Reduction of recurrences over 6 month (%)

ARTI

90

GE

77.7

GE

83.3

ARTI

80

ARTI

71.4

ARTI

88.8

0.03

ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections. P < 0.05 taken as significant. -: not significant.

Details of recurrent infections before, after 3 month of iron supplementation and 6 months follow up. ARTI 20 (16.5%) GE 9 (7.4%) GE 12 (14%) ARTI 10 (11.6%) ARTI 7 (16%) ARTI 9 (22.5%) ARTI 4 (2.4%) GE 2 (1.6%) GE 2 (1.6%) ARTI 1 (0.8%) ARTI 1 (1%) ARTI 2 (2%) ARTI 2 (1.6%) GE 2 (1.6%) GE 2 (2.3%) ARTI 2 (2.3%) ARTI 2 (4.5%) ARTI 1 (2.5%) ARTI 90 GE 77.7 GE 83.3 ARTI 80 ARTI 71.4 ARTI 88.8 ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections. P < 0.05 taken as significant. -: not significant. When considering anemia, in initial ARTI group 121 (73.3%) of them were found to have iron deficiency anemia, 2 of them with megaloblastic anemia and 1 with asymptomatic sickle SD disease. Whiles in initial GE group 86 (71.0%) were found to have iron deficiency anemia, 2 of them with megaloblastic anemia. In UTI group 44 (47.9%) were found to have iron deficiency anemia and 2 of them were thalassemia trait. Further in control 38 (95%) were found to have iron deficiency anemia and 2 of them were thalassemia traits. In the control group, 35 (35%) found to have iron deficiency anemia. We have excluded patients having repeated blood transfusions. Therefore, patients having thalassemia major and other hemoglobinopathies demanding blood transfusions were not considered for the analysis. Based on blood picture analysis, iron deficiency anemia was further confirmed by serum ferritin assay. In initial ARTI patients, serum ferritin level in patients with anemia was 4.5 ± 0.3 ng/ml. In initial GE patients, it was 4.5 ± 0.4 ng/ml, in initial UTI patients it was 4.5 ± 0.35 ng/ml and in control with anemia it was 4.5 ± 0.3 ng/ml. It was significantly (p = 0.03) below the age-specific lower limit of the reference range (<6 ng/ml in both male and female <5 ng/ml years of age). In between anemic children in ARTI, GE, UTI groups and control the serum ferritin values were not significantly differed (p > 0.05). Further, no peripheral stigmata of iron deficiency anemia were observed. All of the subjects were on anti-helminth treatment once in six months. Further patients with GE, non-of them were having amoebic oocytes, cysts and any oocytes related to soil and non-soil inhabiting helminths in wet stool mounts. Also, on iodine staining, all tested diarrheal stool was negative for parasite cyst or ova. Anemia was a risk factor for the development of ARTI with an odds ratio of 3.08 with 95% interval confidence of 2.03–4.80 (P = 0.004) Further anemia was a risk factor for the development of GE with an odds Ratio of 2.98 with 95% interval confidence of 1.93–4.40 (P = 0.01). In UTI group anemia was not either risk or a protective factor as the odds ratio of 1.03 (p = 0.09) with 95% interval confidence of 0.78–1.40. Over the 18 months follow up period development of recurrent ARTI, GE and UTI in study groups and the control as follows. Among initial ARTI group, development of recurrent ARTI was 24 (14.5%, p = 0.03); recurrent GE was 11 (6.5%, p = 0.06) and recurrent UTI was 0. Among initial GE group, development of; recurrent GE was 14 (11.3%, p = 0.03), recurrent ARTI was 11 (8.9%, p = 0.04) and recurrent UTI was 4 (3.2%, p = 0.07). Among initial UTI group, development of; recurrent UTI was 8 (8.3%, p = 0.04), recurrent ARTI was 4 (4.1%, p = 0.06) and recurrent GE was 0. Among control, development of; recurrent ARTI was 11 (11%, p = 0.03), recurrent GE was 6 (6%, p = 0.06) and recurrent UTI was 2 (2%, p = 0.08). For the risk factor analysis, only significant (p < 0.05) recurrent infections among study groups was included (Table 2).
Table 2

Factors associated with development of recurrent acute respiratory tract infection (ARTI), gastroenteritis (GE) and urinary tract infection (UTI) among followed up ARTI, GE, UTI and control groups.

Initial diseaseARTIGEUTIControlP value and comments
Significant recurrent infection in above disease groupsARTIOR (95% CI)GEOR (95% CI)ARTIOR (95% CI)UTIOR (95% CI)ARTIOR (95% CI)
Risk factors
Sex
   Male1.6 (1. 5–1.8)0.03
   Female1.6 (1.4–1.8)0.04

Height for age

(<−2 SD)

2.6 (2.1–3.1®)1.6 (1.4–1.8)*1.6 (1.4–1.8)µ1.6 (1.4–1.8)0.03®, 0.04*, 0.04µ, 0.04
Hb (<11 g/dL)5.2 (4.5–5.9)®3.6 (3.1–4.1)*4.5 (4.0–4.9)µ4.2 (3.4–4.9)0.03®, 0.04*, 0.04µ, 0.04
Constipation2.6 (2.2–3.0)0.04
Water intake <1l1.7 (1.4–2.0)0.04
Hand washing prior to handling of child1.5 (1.3–1.7)µ1.8 (1.3–2.2)0.03µ, 0.04
National program of immunization coverage100%100%100%100%100%
Anti-helminth use-every 6 months86%88%84%90%88%

ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections, LSCS- lower segmental caesarian section, OR- odds ratio, SD- standard deviation. Only significant factors were included. P < 0.05 taken as significant. -: not significant.

Factors associated with development of recurrent acute respiratory tract infection (ARTI), gastroenteritis (GE) and urinary tract infection (UTI) among followed up ARTI, GE, UTI and control groups. Height for age (<−2 SD) ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections, LSCS- lower segmental caesarian section, OR- odds ratio, SD- standard deviation. Only significant factors were included. P < 0.05 taken as significant. -: not significant. Among initial ARTI group for the development of recurrent ARTI; male sex, height for age <−2 SD and Hb% <11 g/dL were significant risk factors whiles in initial GE group for the development of recurrent GE; height for age <−2 SD, Hb% <11 g/dL and not washing hands prior to handling of child were significant risk factors. Also, in initial GE group for the occurrence of recurrent ARTI; height for age <−2 SD, Hb% <11 g/dL and not washing hands prior to handling of the child were significant risk factors. Further, among initial UTI group for the occurrence of recurrent UTI; female sex, constipation, low water intake, and structural malformations were significant risk factors. In addition, among control group for the occurrence of recurrent ARTI; height for age <−2 SD and Hb% <11 g/dL were significant risk factors. None of these factors were not associated significantly (p > 0.05) with recurrences in test subjects and the control. Birth weight (<2500 g), maturity (<36 weeks period of amenorrhea), mode of delivery (normal vaginal or caesarian section), weight for age (<−2 SD), type of drinking water source (tap, tank or spring), use of boiled cooled water, having daily bath and frequent (>2/day) body wash, exclusive breast feeding in first 4 months, family monthly income <30,000 rupees, mothers’/caregivers’ education (only up to primary level), proper waste disposal, birth order (3rd or more in order) and day care attendee, having congenital anomalies including cyanotic heart diseases, cystic fibrosis, structural anomalies in gastro-intestinal tract familial syndromes, having gastro-esophageal reflux and bronchial asthma. Following a period of 3-month of iron supplementation (60–120 mg daily), the subjects were further followed up period of 6-month to observe the development of recurrent ARTI and GE. Meanwhile, advice on hand hygiene was also given. Recurrent infection among anemics as follow: initial ARTI subjects recurrent ARTI was detected in 20 (16.5%), recurrent GE was detected in 9 (7.4%); initial GE subjects recurrent GE was detected in 12 (10%), recurrent ARTI was detected in 10 (12%); initial UTI subjects development of recurrent ARTI was detected in 7 (16%) and control subjects development of recurrent ARTI was detected in 9 (25%). Following 3-month oral iron supplementation hemoglobin concentration was increased significantly and (mean ± SD) mg/Dl as follows: initial ARTI- 11.3 ± 0.2 (p = 0.03), GE- 11.6 ± 0.4 (P = 0.03), UTI- 11.4 ± 0.3 (P = 0.03) and controls- 11.9 ± 0.3 (p = 0.03). serum ferritin was increased significantly and (mean ± SD) ng/ml as follows: initial ARTI- 12.6 ± 0.8 (p = 0.02), GE- 12.6 ± 0.4 (P = 0.02), UTI- 12.6 ± 0.8 (P = 0.02) and controls- 12.2 ± 0.7 (p = 0.02). Recurrent infection rates were reduced significantly. Initial ARTI subjects recurrent ARTI was detected in 2 (1.6%), recurrent GE was detected in 2 (1.6%); initial GE subjects recurrent GE was detected in 2 (10%), recurrent ARTI was detected in 2 (12%); initial UTI subjects recurrent ARTI was detected in 2 (16%) and control subjects recurrent ARTI was detected in 1 (25%). Reduction of recurrences over 6-month follow up as follows: Initial ARTI subjects recurrent ARTI was reduced 90%, recurrent GE was reduced in 77.7%; initial GE subjects recurrent GE was reduced in 83.3%, recurrent ARTI was reduced in 80%; initial UTI subjects recurrent ARTI was reduced in 71.4% and control subjects recurrent ARTI was reduced in 88.8% (Table 1). In subjects with normal hemoglobin the recurrent infections as follows. In initial ARTI group, development of; recurrent ARTI was 4 (2.4%, p = 0.09), recurrent GE was 2 (1.6%, p = 0.07) and recurrent UTI was 0. Among initial GE group, development of; recurrent GE was 2 (1.6%, p = 0.08), recurrent ARTI was 1 (0.8%, p = 0.1) and recurrent UTI was 0 (0%, p = 0.07). Among initial UTI group, development of; recurrent UTI was 1 (1%, p = 0.14), recurrent ARTI was 0 (0%, p = 0.06) and recurrent GE was 0. Among control, development of; recurrent ARTI was 2 (2%, p = 0.06), recurrent GE was 1 (1%, p = 0.07) and recurrent UTI was 1 (1%, p = 0.07). All were not significant (p > 0.05). In initial ARTI patients out of 121 children with anemia viral etiology was detected in 52 (43%) cases. Respiratory syncytial virus (RSV) was commonly detected in the virus (60%) in children with ARTI. In initial GE patients out of 86, children with anemia etiology (viral-44, bacterial-2) were detected in 56 (65%) cases. Rotavirus (57%) was commonly detected in children with GE. In initial UTI patients out of 44 children with anemia, etiology was detected in 36 (82%) cases. E. coli (64%) was commonly detected in children with UTI. Etiology of initial ARTI, GE and UTI groups and subsequent recurrences over the follow-up period following oral iron supplementation was displayed on Table 3. Recurrences following RSV was common in initial ARTI as well as other groups. Also, recurrences following RV was common in initial GE as well as other groups. The overall rate of RSV and RV recurrence in all groups have significantly reduced following oral iron supplementation (Table 3).
Table 3

Etiology of recurrent infections before, after 3 month of iron supplementation and 6 months follow up.

Initial group anemics (n)ARTI (121)GE (86)UTI (44)Control (35)
Etiology

Viral etiology -52 (43%)

RSV- 31 (26%), PIV1-3 (2.5%), PIV 2–3 (2.5%), AV-2 (1.6%), hMPV-4 (3.3%), Influenza A- 6 (5%), Influenza B- 3 (2.5%),

No etiology 69 (57%)

Etiology detected -56 (65%)

RV-32 (37%), AV(g)- 12 (14%),

Shigella sonnei-2 (2.3%)

No etiology -30 (35%)

Bacterial etiology -36 (82%)

Escherichia coli- 23 (53%), Klebsiella pneumoniae-6 (14%), Staphylococcus aureus- 2(4.5%), proteus sp.-3(6.7%)

No etiology -8 (18%)

Significant recurrent infections among anemics

ARTI

20

(16.5%)

GE

9

(7.4%)

GE

12

(10%)

ARTI

10

(12%)

ARTI

7

(16%)

ARTI

9

(25%)

EtiologyRSV- 18 (90%), Influenza A- 2 (10%)RV-8 (89%), AV- 1 (11%)RV-10 (83%), AV- 2 (17%)RSV-10 (100%)RSV-7 (100%)RSV-8 (89%) AV-1 (11%)
3-month Iron supplementation
ARTIGEUTIControl
Recurrent infection at 6 months follow up

ARTI

2

GE

2

GE

2

ARTI

2

ARTI

2

ARTI

1

EtiologyRSV-2 (100%)RV-2 (100%)RV-2 (100%)RSV-2 (100%)RSV-2 (100%)RSV-1 (100%)

ARTI- acute respiratory tract infections, UTI- urinary tract infection, GE-gastro-enteritis, RSV-Respiratory syncytial virus, AV- Adenovirus, %), PIV1-parainfluenza virus-1, PIV 2- parainfluenza virus-2, hMPV-human Metapneumovirus, AV(g)- adenovirus causing gastro-enteritis.

Etiology of recurrent infections before, after 3 month of iron supplementation and 6 months follow up. Viral etiology -52 (43%) RSV- 31 (26%), PIV1-3 (2.5%), PIV 2–3 (2.5%), AV-2 (1.6%), hMPV-4 (3.3%), Influenza A- 6 (5%), Influenza B- 3 (2.5%), No etiology 69 (57%) Etiology detected -56 (65%) RV-32 (37%), AV(g)- 12 (14%), Shigella sonnei-2 (2.3%) No etiology -30 (35%) Bacterial etiology -36 (82%) Escherichia coli- 23 (53%), Klebsiella pneumoniae-6 (14%), Staphylococcus aureus- 2(4.5%), proteus sp.-3(6.7%) No etiology -8 (18%) ARTI 20 (16.5%) GE 9 (7.4%) GE 12 (10%) ARTI 10 (12%) ARTI 7 (16%) ARTI 9 (25%) ARTI 2 GE 2 GE 2 ARTI 2 ARTI 2 ARTI 1 ARTI- acute respiratory tract infections, UTI- urinary tract infection, GE-gastro-enteritis, RSV-Respiratory syncytial virus, AV- Adenovirus, %), PIV1-parainfluenza virus-1, PIV 2- parainfluenza virus-2, hMPV-human Metapneumovirus, AV(g)- adenovirus causing gastro-enteritis. Further, primary or secondary immunodeficiency was not detected in any of the subjects including the control.

Discussion

Childhood nutritional anemia would reflect the status of chronic malnutrition[15,16]. The world health organization estimates that globally around 293 million young children suffer from anemia, among which 50% are estimated to be attributable to iron deficiency. Iron deficiency anemia can be present at early age and also in well-nourished children[21]. Iron deficiency is one of the most common micronutrient deficiencies in the world[22]. Children are vulnerable for various infections specially ARTI, UTI and GE[10,11]. Such infections could be associated with a low level of immunity. Frequent exposure and low level of hygienic practices are associated with recurrences[11,35]. Once recurrent infections are associated with childhood under-nutrition the outcome would worsen often ended up with frequent infections in early life. This is a modifiable risk factor for the development of infections[16,18]. While adherence to hygienic practices, consumption of nutritionally adequate diet would lead to alleviating the burden[16,35]. In our study, the risk of childhood ARTI was significantly associated with iron deficiency anemia. Blood iron deficiency is a risk factor for the development of recurrent ARTIs[25,26]. Mourad et al. and Ramakrishnan et al. shows that iron deficiency anemic children were two times and five times more susceptible to lower respiratory tract infection compared to the control group, respectively[31,36]. Adequate iron is important for proliferation and maturation of immune cells, particularly lymphocytes, for generation of specific response to infection[37]. Further the observed risk could be due to low oxygen carrying capacity in pulmonary vasculature and parenchyma leading to the low level of protectively towards invading pathogens. Among viral ARTI, recurrence was common following RSV. Is the most prevalent virus among childhood ARTI and frequent exposure would lead to recurrences. RSV is considered one of the earliest stimuli for recurrent wheezing in children[38]. The supplementation of iron in healthy childhood community has reduced upper respiratory tract infections significantly[38-40]. Iron deficiency is a risk factor for the development of GE. Also, GE would be associated with malnutrition. Since gastric epithelium having a high turnover rate, it requires well nourish status for maintenance of mucosal integrity and absorptive capability[41,42]. Further cumulatively low level of nutrition leads to low immunity. Rotavirus was detected as commonest etiology for childhood GE as well as recurrent GE. Frequent exposure would lead to recurrences[43]. In here, the stool was tested only in single sample helminth infestation cannot be excluded. Continuous use of anti-helminth thus leads to the low incidence of helminth infestation. Interestingly, anemia is neither a risk factor nor a protective factor for the development of childhood UTI. Level of immunity perhaps with low in mal-nutrition but low level of hydration is key to the development of UTI. In addition to that structural malformations and anatomical anomalies act simultaneously for the acquisition of childhood UTI[44]. Following iron supplementation hemoglobin concentration rose, became normal for age and sex. The increase in serum ferritin reflects the correction of iron storages. Over the follow-up period, recurrent ARTI and GE among tested groups were significantly reduced thus indicating replenishing iron in blood plays a significant protective role in childhood recurrent ARTI and GE. World Health Organization advice to supplement iron to prevent iron deficiency in the population to minimize infections[37,45,46]. Meanwhile, advice on hand hygiene and sanitary practices were also given as health education. Sri Lanka comprises well spread public health facilities with great awareness but the majority of children suffer anemia. Although we did not collect data on dietary intake of infants (except breast milk intake and introduction of solid/semisolid foods), evidence from other studies from rural Sri Lanka suggests that dietary diversity is low and might also be responsible for anemia[47,48]. Poverty will be a key factor[23,46]. Also feeding mal-practices and lack of knowledge on nutritive food materials would aggravate it. It is important that implementation of ground-level education on nutrition and supplementation of macro and micro-nutrients on a regular basis. This would reduce the level of childhood infections and associated burden. Here, we haven’t measured the level of adherence to hand hygiene and sanitary practices. This could be a confounding factor on the reduction of infections and the recurrences.

Conclusion

Children are vulnerable for developing various infections specially ARTI, UTI and GE. Iron deficient children are more prone to develop recurrent ARTI, GE and iron deficiency anemia would worsen the associated burden. Once iron deficiency being corrected the rate of recurrent ARTI and GE was reduced. This would be a boost for policy developers to implement strategies at the community level to prevent iron deficiency in children to reduce ARTI and GE recurrences.
  7 in total

Review 1.  [Role of iron in immunity and its relation with infections].

Authors:  A Soyano; M Gómez
Journal:  Arch Latinoam Nutr       Date:  1999-09

Review 2.  Effect of iron-fortified foods on hematologic and biological outcomes: systematic review of randomized controlled trials.

Authors:  Tarun Gera; Harshpal Singh Sachdev; Erick Boy
Journal:  Am J Clin Nutr       Date:  2012-07-03       Impact factor: 7.045

3.  Infectious disease burden related to child day care in the Netherlands.

Authors:  Remko Enserink; Rolf Ypma; Gé A Donker; Henriette A Smit; Wilfrid van Pelt
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

4.  Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever.

Authors:  A Hoberman; E R Wald; E A Reynolds; L Penchansky; M Charron
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

5.  Nutritional anemia in young children with focus on Asia and India.

Authors:  Prakash V Kotecha
Journal:  Indian J Community Med       Date:  2011-01

6.  Primary immunodeficiency in infection-prone children in southern Sweden: occurrence, clinical characteristics and immunological findings.

Authors:  Nicholas Brodszki; Göran Jönsson; Lillemor Skattum; Lennart Truedsson
Journal:  BMC Immunol       Date:  2014-08-14       Impact factor: 3.615

7.  A case series on common cold to severe bronchiolitis and pneumonia in children following human metapneumovirus infection in Sri Lanka.

Authors:  J A A S Jayaweera; F Noordeen; S Kothalaweala; F N N Pitchai; M L M Rayes
Journal:  BMC Res Notes       Date:  2018-02-14
  7 in total
  16 in total

1.  Experience in Nutrition Management of Diabetes-Affected COVID-19 Patients.

Authors:  Behnaz Abiri; Paul C Guest; Mohammadreza Vafa
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Serum Iron and Ferritin Levels Are Correlated with Complement C3.

Authors:  Shuang Wen; Yeqin Sha; Yinling Li; Zhilian Rui; Chenhong Si; Yuning Zhou; Fengfeng Yan; Bicheng Wang; Jingming Hu; Xu Han; Dongyan Shi
Journal:  Biol Trace Elem Res       Date:  2020-09-15       Impact factor: 3.738

3.  The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.

Authors:  Philip T James; Zakari Ali; Andrew E Armitage; Ana Bonell; Carla Cerami; Hal Drakesmith; Modou Jobe; Kerry S Jones; Zara Liew; Sophie E Moore; Fernanda Morales-Berstein; Helen M Nabwera; Behzad Nadjm; Sant-Rayn Pasricha; Pauline Scheelbeek; Matt J Silver; Megan R Teh; Andrew M Prentice
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.798

Review 4.  Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis.

Authors:  Mohammed Iddir; Alex Brito; Giulia Dingeo; Sofia Sosa Fernandez Del Campo; Hanen Samouda; Michael R La Frano; Torsten Bohn
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

Review 5.  A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19.

Authors:  Mohammad Taheri; Ali Bahrami; Parisa Habibi; Fatemeh Nouri
Journal:  Biol Trace Elem Res       Date:  2020-09-08       Impact factor: 3.738

6.  Potential interventions for novel coronavirus in China: A systematic review.

Authors:  Lei Zhang; Yunhui Liu
Journal:  J Med Virol       Date:  2020-03-03       Impact factor: 2.327

Review 7.  Encapsulated Food Products as a Strategy to Strengthen Immunity Against COVID-19.

Authors:  Soubhagya Tripathy; Deepak Kumar Verma; Mamta Thakur; Ami R Patel; Prem Prakash Srivastav; Smita Singh; Mónica L Chávez-González; Cristobal N Aguilar
Journal:  Front Nutr       Date:  2021-05-21

Review 8.  Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.

Authors:  Navid Koleini; Jason S Shapiro; Justin Geier; Hossein Ardehali
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

Review 9.  A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention.

Authors:  Savita Budhwar; Kashika Sethi; Manali Chakraborty
Journal:  Curr Nutr Rep       Date:  2020-09

Review 10.  Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?

Authors:  Ana H A Morais; Thais S Passos; Bruna L L Maciel; Juliana K da Silva-Maia
Journal:  Nutrients       Date:  2020-06-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.